Jennifer E. Koblinski

3.7k total citations
71 papers, 2.7k citations indexed

About

Jennifer E. Koblinski is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jennifer E. Koblinski has authored 71 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 27 papers in Oncology and 19 papers in Cancer Research. Recurrent topics in Jennifer E. Koblinski's work include Cell Adhesion Molecules Research (16 papers), Protease and Inhibitor Mechanisms (10 papers) and Cancer Cells and Metastasis (7 papers). Jennifer E. Koblinski is often cited by papers focused on Cell Adhesion Molecules Research (16 papers), Protease and Inhibitor Mechanisms (10 papers) and Cancer Cells and Metastasis (7 papers). Jennifer E. Koblinski collaborates with scholars based in United States, Japan and Australia. Jennifer E. Koblinski's co-authors include Bonnie F. Sloane, Mamoun Ahram, Hynda K. Kleinman, Irina Arnaoutova, Jay George, Gabriel Benton, Kamiar Moin, Hidayatullah G. Munshi, Mikhail G. Dozmorov and Madhavi Puchalapalli and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Jennifer E. Koblinski

67 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jennifer E. Koblinski United States	27	1.3k	829	752	348	317	71	2.7k
Shin Jung South Korea	34	1.2k 0.9×	599 0.7×	461 0.6×	295 0.8×	315 1.0×	204	4.0k
Christopher S. Gondi United States	32	1.6k 1.2×	772 0.9×	1.1k 1.5×	165 0.5×	225 0.7×	70	2.8k
Kamiar Moin United States	30	1.1k 0.8×	743 0.9×	1.2k 1.6×	262 0.8×	404 1.3×	50	2.4k
Amin Hajitou United Kingdom	29	1.7k 1.3×	663 0.8×	569 0.8×	181 0.5×	295 0.9×	64	3.0k
Lars H. Engelholm Denmark	31	1.3k 1.0×	1.1k 1.3×	1.2k 1.5×	185 0.5×	416 1.3×	79	3.4k
Isao Kii Japan	31	1.7k 1.3×	835 1.0×	338 0.4×	125 0.4×	256 0.8×	64	3.3k
Maurizio Mongiat Italy	29	1.3k 1.0×	559 0.7×	550 0.7×	154 0.4×	656 2.1×	65	2.6k
Meenakshi A. Chellaiah United States	32	1.9k 1.5×	1.0k 1.2×	475 0.6×	203 0.6×	755 2.4×	55	3.2k
Tracy Vargo-Gogola United States	21	995 0.8×	914 1.1×	537 0.7×	400 1.1×	181 0.6×	28	2.1k
Barbara Garmy‐Susini France	28	1.8k 1.4×	1.0k 1.3×	653 0.9×	173 0.5×	301 0.9×	65	3.2k

Countries citing papers authored by Jennifer E. Koblinski

Since Specialization

Citations

This map shows the geographic impact of Jennifer E. Koblinski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer E. Koblinski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer E. Koblinski more than expected).

Fields of papers citing papers by Jennifer E. Koblinski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer E. Koblinski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer E. Koblinski. The network helps show where Jennifer E. Koblinski may publish in the future.

Co-authorship network of co-authors of Jennifer E. Koblinski

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer E. Koblinski. A scholar is included among the top collaborators of Jennifer E. Koblinski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer E. Koblinski. Jennifer E. Koblinski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Slator, Creina, Raphael Enoque Ferraz de Paiva, Sriram KK, et al.. (2025). A trackable trinuclear platinum complex for breast cancer treatment. Nucleic Acids Research. 53(13). 1 indexed citations

Khader, Adam, et al.. (2025). High dose acetaminophen re-polarizes CD11b+ cells in the tumor microenvironment towards an activated macrophage phenotype. Neoplasia. 64. 101155–101155.

Koblinski, Jennifer E., Swati Palit Deb, Jorge J. Nieva, et al.. (2024). Oncogenic Mutant p53 Sensitizes Non–Small Cell Lung Cancer Cells to Proteasome Inhibition via Oxidative Stress–Dependent Induction of Mitochondrial Apoptosis. Cancer Research Communications. 4(10). 2685–2698. 3 indexed citations

Guo, Chunqing, Xiaoyan Deng, Anthony C. Faber, et al.. (2024). The Innate Immune System and the TRAIL–Bcl-XL Axis Mediate a Sex Bias in Lung Cancer and Confer a Therapeutic Vulnerability in Females. Cancer Research. 84(24). 4140–4155. 2 indexed citations

Menon, Vijay, et al.. (2023). Antitumor active trans‑platinum complexes through metabolic stability and enhanced cellular accumulation. Journal of Inorganic Biochemistry. 252. 112475–112475.

Li, Howard, Tytus Bernaś, Jennifer E. Koblinski, et al.. (2023). High-Dose Acetaminophen with N-acetylcysteine Rescue Inhibits M2 Polarization of Tumor-Associated Macrophages. Cancers. 15(19). 4770–4770. 5 indexed citations

Jacob, Sheeba, Jinyang Cai, Konstantinos V. Floros, et al.. (2022). Genomic screening reveals ubiquitin-like modifier activating enzyme 1 as a potent and druggable target in c-MYC-high triple negative breast cancer models. PNAS Nexus. 1(5). pgac232–pgac232. 6 indexed citations

Floros, Konstantinos V., Jinyang Cai, Sheeba Jacob, et al.. (2021). MYCN -Amplified Neuroblastoma Is Addicted to Iron and Vulnerable to Inhibition of the System Xc-/Glutathione Axis. Cancer Research. 81(7). 1896–1908. 104 indexed citations

Heisey, Daniel A.R., Sheeba Jacob, Timothy L. Lochmann, et al.. (2021). Pharmaceutical Interference of the EWS-FLI1–driven Transcriptome By Cotargeting H3K27ac and RNA Polymerase Activity in Ewing Sarcoma. Molecular Cancer Therapeutics. 20(10). 1868–1879. 11 indexed citations

10.

Wang, Dongdong, Nayden G. Naydenov, Mikhail G. Dozmorov, Jennifer E. Koblinski, & Andrei I. Ivanov. (2020). Anillin regulates breast cancer cell migration, growth, and metastasis by non-canonical mechanisms involving control of cell stemness and differentiation. Breast Cancer Research. 22(1). 3–3. 38 indexed citations

11.

Craig, Justin M., et al.. (2020). Inhibition of the Activity of Cyclophilin A Impedes Prolactin Receptor-Mediated Signaling, Mammary Tumorigenesis, and Metastases. iScience. 23(10). 101581–101581. 7 indexed citations

12.

Bajpai, Richa, Kehinde Adekola, Irawati Kandela, et al.. (2014). Targeting the Metabolic Plasticity of Multiple Myeloma with FDA-Approved Ritonavir and Metformin. Clinical Cancer Research. 21(5). 1161–1171. 123 indexed citations

13.

Benton, Gabriel, Irina Arnaoutova, Jay George, Hynda K. Kleinman, & Jennifer E. Koblinski. (2014). Matrigel: From discovery and ECM mimicry to assays and models for cancer research. Advanced Drug Delivery Reviews. 79-80. 3–18. 361 indexed citations

14.

Malin, Dmitry, et al.. (2011). Enhanced Metastasis Suppression by Targeting TRAIL Receptor 2 in a Murine Model of Triple-Negative Breast Cancer. Clinical Cancer Research. 17(15). 5005–5015. 44 indexed citations

15.

Ghosh, Supurna, Jennifer E. Koblinski, Jeffrey J. Johnson, et al.. (2010). Urinary-Type Plasminogen Activator Receptor/α3β1 Integrin Signaling, Altered Gene Expression, and Oral Tumor Progression. Molecular Cancer Research. 8(2). 145–158. 20 indexed citations

16.

Moore, Finola E., Evan C. Osmundson, Jennifer E. Koblinski, et al.. (2010). The WW-HECT protein Smurf2 interacts with the Docking Protein NEDD9/HEF1 for Aurora A activation. Cell Division. 5(1). 22–22. 19 indexed citations

17.

Joseph, Mathew J., Surabhi Dangi‐Garimella, Mario A. Shields, et al.. (2009). Slug is a downstream mediator of transforming growth factor‐β1‐induced matrix metalloproteinase‐9 expression and invasion of oral cancer cells. Journal of Cellular Biochemistry. 108(3). 726–736. 73 indexed citations

18.

Zheng, Jiamao, et al.. (2008). Prolyl Isomerase Cyclophilin A Regulation of Janus-Activated Kinase 2 and the Progression of Human Breast Cancer. Cancer Research. 68(19). 7769–7778. 61 indexed citations

19.

Engbring, Jean A., et al.. (2008). The laminin α-1 chain derived peptide, AG73, increases fibronectin levels in breast and melanoma cancer cells. Clinical & Experimental Metastasis. 25(3). 241–252. 7 indexed citations

20.

Bos, Timothy J., Susan L. Cohn, Jennifer E. Koblinski, et al.. (2004). International hermelin brain tumor symposium on matricellular proteins in normal and cancer cell-matrix interactions. Matrix Biology. 23(1). 63–69. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact